These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34274595)

  • 1. Evaluation of hydrogen peroxide virucidal efficacy against yellow fever virus 17DD vaccine strain for application in a vaccine manufacturing industry.
    Ferreira Ballestê Ajorio AC; Pessanha Rhodes V; Peclat Rodrigues A; Mercês Moreira F; Alvaro Diniz V; Machado Vieira Mattoso J; Barbosa da Silva I; da Silva Guedes Junior D; Lima Brandão ML
    J Pharm Biomed Anal; 2021 Sep; 204():114264. PubMed ID: 34274595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of hydrogen peroxide efficacy against AZD1222 chimpanzee adenovirus strain in the recombinant COVID-19 vaccine for application in cleaning validation in a pharmaceutical manufacturing industry.
    Ajorio ACFB; Rhodes VP; Rodrigues AP; Diniz VA; Mattoso JMV; da Silva IB; D Aiuto DMM; Brandão MLL
    Lett Appl Microbiol; 2022 Apr; 74(4):536-542. PubMed ID: 34921425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of hydrogen peroxide wipes for decontamination of AZD1222 adenovirus COVID-19 vaccine strain on pharmaceutical industry materials.
    Rhodes VP; Ajorio ACFB; da Costa LV; Rodrigues AP; Diniz VA; da Silva Lage RV; da Silva IB; Brandão MLL
    Lett Appl Microbiol; 2022 Dec; 75(6):1639-1644. PubMed ID: 36073022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virucidal efficacy of hydrogen peroxide vapour disinfection.
    Tuladhar E; Terpstra P; Koopmans M; Duizer E
    J Hosp Infect; 2012 Feb; 80(2):110-5. PubMed ID: 22153909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys.
    Trindade GF; Marchevsky RS; Fillipis AM; Nogueira RM; Bonaldo MC; Acero PC; Caride E; Freire MS; Galler R
    An Acad Bras Cienc; 2008 Jun; 80(2):311-21. PubMed ID: 18506257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures.
    Pereira RC; Silva AN; Souza MC; Silva MV; Neves PP; Silva AA; Matos DD; Herrera MA; Yamamura AM; Freire MS; Gaspar LP; Caride E
    Vaccine; 2015 Aug; 33(35):4261-8. PubMed ID: 25862300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virucidal Activity of Fogged Chlorine Dioxide- and Hydrogen Peroxide-Based Disinfectants against Human Norovirus and Its Surrogate, Feline Calicivirus, on Hard-to-Reach Surfaces.
    Montazeri N; Manuel C; Moorman E; Khatiwada JR; Williams LL; Jaykus LA
    Front Microbiol; 2017; 8():1031. PubMed ID: 28642746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hydrogen peroxide gaseous disinfection systems to decontaminate viruses.
    Pottage T; Richardson C; Parks S; Walker JT; Bennett AM
    J Hosp Infect; 2010 Jan; 74(1):55-61. PubMed ID: 19931937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
    Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
    Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the virucidal efficacy of hydrogen peroxide vapour.
    Goyal SM; Chander Y; Yezli S; Otter JA
    J Hosp Infect; 2014 Apr; 86(4):255-9. PubMed ID: 24656442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure-inactivated yellow fever 17DD virus: implications for vaccine development.
    Gaspar LP; Mendes YS; Yamamura AM; Almeida LF; Caride E; Gonçalves RB; Silva JL; Oliveira AC; Galler R; Freire MS
    J Virol Methods; 2008 Jun; 150(1-2):57-62. PubMed ID: 18420285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys.
    Marchevsky RS; Freire MS; Coutinho ES; Galler R
    Virology; 2003 Nov; 316(1):55-63. PubMed ID: 14599790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Novel Process Indicators for Rapid Monitoring of Hydrogen Peroxide Decontamination Processes.
    McLeod NP; Clifford M; Sutton JM
    PDA J Pharm Sci Technol; 2017; 71(5):393-404. PubMed ID: 28512177
    [No Abstract]   [Full Text] [Related]  

  • 16. Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
    Pestana CP; Lawson-Ferreira R; Lessa-Aquino C; Leal MDLF; Freire MDS; Homma A; Medeiros MA
    J Virol Methods; 2018 Oct; 260():82-87. PubMed ID: 30009851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virucidal Efficacy of a Hydrogen Peroxide Nebulization Against Murine Norovirus and Feline Calicivirus, Two Surrogates of Human Norovirus.
    Zonta W; Mauroy A; Farnir F; Thiry E
    Food Environ Virol; 2016 Dec; 8(4):275-282. PubMed ID: 27384526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for interferon production and its correlation with YF 17DD vaccine virus yields in primary chick embryo cells.
    Caride E; Borges MB; Marcovistz R; Galler R; Freire Mda S
    Virus Res; 2008 Oct; 137(1):106-11. PubMed ID: 18621087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
    Guirakhoo F; Kitchener S; Morrison D; Forrat R; McCarthy K; Nichols R; Yoksan S; Duan X; Ermak TH; Kanesa-Thasan N; Bedford P; Lang J; Quentin-Millet MJ; Monath TP
    Hum Vaccin; 2006; 2(2):60-7. PubMed ID: 17012873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial.
    Camacho LA; Freire Mda S; Leal Mda L; Aguiar SG; Nascimento JP; Iguchi T; Lozana Jde A; Farias RH;
    Rev Saude Publica; 2004 Oct; 38(5):671-8. PubMed ID: 15499438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.